BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver Int. 2018;38:399-411. [PMID: 28921801 DOI: 10.1111/liv.13591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Li W, Alamoudi JA, Gautam N, Kumar D, Olivera M, Gwon Y, Mukgerjee S, Alnouti Y, Santra A. Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases. International Journal of Hepatology 2022;2022:1-17. [DOI: 10.1155/2022/5473752] [Reference Citation Analysis]
2 Gerber LH, Weinstein AA, Mehta R, Younossi ZM. Importance of fatigue and its measurement in chronic liver disease. World J Gastroenterol 2019; 25(28): 3669-3683 [PMID: 31391765 DOI: 10.3748/wjg.v25.i28.3669] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
3 Seth RK, Kimono D, Alhasson F, Sarkar S, Albadrani M, Lasley SK, Horner R, Janulewicz P, Nagarkatti M, Nagarkatti P, Sullivan K, Chatterjee S. Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness. Toxicol Appl Pharmacol 2018;350:64-77. [PMID: 29751049 DOI: 10.1016/j.taap.2018.05.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
4 European Association for the Study of the Liver. Electronic address: jhepatology@easloffice.eu., European Association for the Study of the Liver. EASL Clinical Practice Guidelines on Sclerosing Cholangitis. J Hepatol 2022:S0168-8278(22)00326-9. [PMID: 35738507 DOI: 10.1016/j.jhep.2022.05.011] [Reference Citation Analysis]
5 Van Campenhout S, Van Vlierberghe H, Devisscher L. Common Bile Duct Ligation as Model for Secondary Biliary Cirrhosis. Methods Mol Biol. 2019;1981:237-247. [PMID: 31016658 DOI: 10.1007/978-1-4939-9420-5_15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
6 Ranieri V, Kennedy E, Walmsley M, Thorburn D, McKay K. Rare but heard: using asynchronous virtual focus groups, interviews and roundtable discussions to create a personalised psychological intervention for primary sclerosing cholangitis: a protocol. BMJ Open 2019;9:e031417. [PMID: 31578198 DOI: 10.1136/bmjopen-2019-031417] [Reference Citation Analysis]
7 . UEG Week 2018 Poster Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792819] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Rana P, Gupta P, Chaluvashetty SB, Mittal A, Kalra N, Dutta U, Sandhu MS. Interventional radiological management of hepatobiliary disorders in pregnancy. Clin Exp Hepatol 2020;6:176-84. [PMID: 33145424 DOI: 10.5114/ceh.2020.99508] [Reference Citation Analysis]
9 Tabibian JH, Bowlus CL. Primary sclerosing cholangitis: A review and update. Liver Res. 2017;1:221-230. [PMID: 29977644 DOI: 10.1016/j.livres.2017.12.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
10 Cury DB, Oliveira R, Cury MS. Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - a follow-up study in a private inflammatory bowel disease center (2003-2017). J Inflamm Res 2019;12:127-35. [PMID: 31213873 DOI: 10.2147/JIR.S190929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
11 Sasamori Y, Tanaka A, Ayabe T. Liver disease in pregnancy. Hepatol Res 2020;50:1015-23. [PMID: 32583511 DOI: 10.1111/hepr.13540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Qian J, Jiao Y, Wang G, Liu H, Cao X, Yang H. Mechanism of TGF-β1 inhibiting Kupffer cell immune responses in cholestatic cirrhosis. Exp Ther Med 2020;20:1541-9. [PMID: 32742385 DOI: 10.3892/etm.2020.8826] [Reference Citation Analysis]
13 Marcus E, Stone P, Krooupa AM, Thorburn D, Vivat B. Quality of life in primary sclerosing cholangitis: a systematic review. Health Qual Life Outcomes 2021;19:100. [PMID: 33743710 DOI: 10.1186/s12955-021-01739-3] [Reference Citation Analysis]
14 Sun J, Wang J, Zhang N, Yang R, Chen K, Kong D. Identification of global mRNA expression profiles and comprehensive bioinformatic analyses of abnormally expressed genes in cholestatic liver disease. Gene 2019;707:9-21. [PMID: 31048068 DOI: 10.1016/j.gene.2019.04.078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Vannas M, Färkkilä M, Sintonen H, Åberg F, Isoniemi H. Health-related quality of life before and after liver transplantation in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2020;55:347-53. [PMID: 32191135 DOI: 10.1080/00365521.2020.1725106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tabibian JH, Baron TH. Endoscopic management of primary sclerosing cholangitis. Expert Rev Gastroenterol Hepatol 2018;12:693-703. [PMID: 29883229 DOI: 10.1080/17474124.2018.1483719] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Ranieri V, Kennedy E, Walmsley M, Thorburn D, McKay K. The Primary Sclerosing Cholangitis (PSC) Wellbeing Study: Understanding psychological distress in those living with PSC and those who support them. PLoS One 2020;15:e0234624. [PMID: 32628685 DOI: 10.1371/journal.pone.0234624] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]